News | August 14, 2022
Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022
Subscribe To Our Newsletter & Stay Updated